Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda

Clinical Infectious Diseases

Volumn 62, Issue 2, 2016, Pages 200-207

  Chami, Goylette F ^a   Kontoleon, Andreas A ^a   Bulte, Erwin ^a,c   Fenwick, Alan ^b   Kabatereine, Narcis B ^b,d   Tukahebwa, Edridah M ^d   Dunne, David W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d MINISTRY OF HEALTH   (Uganda)

Author keywords

coverage; mass drug administration; schistosomiasis; soil transmitted helminths; sub Saharan Africa

Indexed keywords

ALBENDAZOLE; PRAZIQUANTEL; ANTHELMINTIC AGENT;

ADULT; ARTICLE; COMMUNITY MEDICINE; EDUCATIONAL STATUS; FEMALE; HEALTH EDUCATION; HOOKWORM; HOOKWORM INFECTION; HOUSEHOLD; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MUSLIM; OCCUPATION; PARASITE CONTROL; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SOCIAL STATUS; UGANDA; YOUNG ADULT; ADOLESCENT; ANIMAL; CHEMOPROPHYLAXIS; CHILD; DISEASE TRANSMISSION; HOOKWORM INFECTIONS; MEDICATION COMPLIANCE; POPULATION GROUP; PREVENTION AND CONTROL; PROCEDURES; RURAL POPULATION;

ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; CHEMOPREVENTION; CHILD; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HOOKWORM INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; POPULATION GROUPS; PRAZIQUANTEL; RURAL POPULATION; SCHISTOSOMIASIS; UGANDA;

EID: 84960102682     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ829     Document Type: Article

References (32)

1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006; 6:411-25.
2. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006; 367:1521-32.
3. World Health Organization. Preventive chemotherapy in human helminthiases, coordinated use of anthelminthic drugs in control interventions: A manual for health professionals and programme managers. 2006. Available at: http://whqlibdoc.who.int/publications/2006/9241547103-eng.pdf. Accessed 1 October 2015.
4. Pinot de Moira A, Fulford A, Kabatereine N, Ouma J, Booth M, Dunne D. Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: The influence of age, sex, ethnicity and IgE. PLoS Negl Trop Dis 2010; 4:e820.
5. Albonico M, Smith P, Ercole E, et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans R Soc Trop Med Hyg 1995; 89:538-41.
6. World Health Organization. Schistosomiasis: number of people receiving preventive chemotherapy in 2012. Wkly Epidemiol Rec 2014; 89:21-8.
7. World Health Organization. Soil-transmitted helminthiases: number of children treated in 2011. Wkly Epidemiol Rec 2013; 88:145-52.
8. Ivan E, Crowther NJ, Mutimura E, et al. Effect of deworming on disease progression markers in HIV-1, infected pregnant women on antiretroviral therapy: A longitudinal observational study from Rwanda. Clin Infect Dis 2015; 60:135-42.
9. Turner HC,Walker M, Churcher TS, et al. Reaching the London declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin Infect Dis 2014; 59:923-32.
10. Knopp S, Mohammed KA, Speich B, et al. Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: A randomized controlled trial. Clin Infect Dis 2010; 51:1420-8.
11. Parker M, Allen T. Does mass drug administration for the integrated treatment of neglected tropical diseases really work? assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda. Health Res Policy Syst 2011; 9:3.
12. Babu B, Kar S. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Trop Med Int Health 2004; 9:702-9.
13. Brieger W, Okeibunor J, Abiose A, et al. Characteristics of persons who complied with and failed to comply with annual ivermectin treatment. Trop Med Int Health 2012; 17:920-30.
14. Brieger W, Otusanya S, Oke G, Oshiname F, Adeniyi J. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria. Trop Med Int Health 2002; 7:11-8.
15. Talbot J, Viall A, Direny A, et al. Predictors of compliance in mass drug administration for the treatment and prevention of lymphatic filariasis in Leogane, Haiti. Am J Trop Med Hyg 2008; 78:283-8.
16. Njomo D, Mukoko D, Nyamongo N, Karanja J. Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: A study of Malindi Town, Kenya. PLoS One 2014; 9:e83413.
17. Njomo D, Amuyunzu-Nyamongo M, Mukoko D, Magambo J, Njenga S. Socioeconomic factors associated with compliance with mass drug administration for lymphatic filariasis elimination in Kenya: descriptive study results. Ann Trop Med PH 2012; 5:103-10.
18. Parker M, Allen T, Pearson G, Peach N, Flynn R, Rees N. Border parasites: schistosomiasis control among Uganda's fisherfolk. J East Afr Stud 2012; 6:98-123.
19. Kabatereine N, Tukahebwa E, Kazibwe F, et al. Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda. Trans R Soc Trop Med Hyg 2006; 100:208-15.
20. Fenwick A, Webster JP, Bosque-Oliva E, et al. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 2009; 136:1719-30.
21. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-400.
22. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. College Station, TX: Stata Press, 2008.
23. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996; 1:30.
24. Peugh JL. A practical guide to multilevel modeling. J Educ Psychol 2010; 48: 85-112.
25. Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol 2013; 4:133-42.
26. Refaeilzadeh P, Tang L, Liu H. Cross-validation. In: Liu L, Özsu MT, eds. Encyclopedia of database systems. New York, NY: Springer US, 2009:532-8.
27. Zhang Y, Koukounari A, Kabatereine N, et al. Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. BMC Med 2007; 5:27.
28. Fleming FM, Fenwick A, Tukahebwa EM, et al. Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programme. Parasitology 2009; 136:1759-69.
29. Chami G, Molyneux D, Kontoleon A, Dunne D. Exploring network theory for mass drug administration. Trends Parasitol 2013; 29:370-9.
30. Worrell C, Mathieu E. Drug coverage surveys for neglected tropical diseases: 10 years of field experience. Am J Trop Med Hyg 2012; 87:216-22.
31. Kabatereine N, Brooker S, Tukahebwa E, Kazibwe F, Onapa A. Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control. Trop Med Int Health 2004; 9:372-80.
32. Kabatereine N, Tukahebwa E, Kazibwe F, et al. Short communication: soil-transmitted helminthiasis in Uganda: epidemiology and cost of control. Trop Med Int Health 2005; 10:1187-9.